Elanco highlights pet health growth. Elanco stock gains 1.05 percent.

Published on 10/06/2026 at 13:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elanco posted USD 1.37 billion revenue in the second quarter. Elanco stock costs EUR 20.23 on October 6, 2026 after EUR 20.02, plus 1.05 percent.

ELAN, US28414H1032, Illustration mit AI erstellt.

Elanco (ISIN US28414H1032) was trading at EUR 20.23 at Lang & Schwarz on October 6, 2026 at 1:18 p.m. CEST, up 1.05 percent from the prior close of EUR 20.02. On September 15, 2026, PRNewswire reported that Elanco's U.S. Pet Health business was on track for high-single digit to low double-digit growth in the second half of 2026, while the stock gained 1.05 percent on the latest Lang & Schwarz snapshot.

Pet health growth reaches 9.00 percent

The commercial story is concentrated in Elanco's innovation portfolio. According to PRNewswire, U.S. and international Pet Health organic constant-currency revenue each increased 9.00 percent year over year in the first half of 2026. The same release said reported international Pet Health revenue growth reached 15.00 percent in that period.

The product momentum is paired with a scheduled reporting date. Elanco lists its third-quarter 2026 earnings call for November 6, 2026, at 8:00 a.m. EST.

Second-quarter results beat estimates

Elanco's second-quarter 2026 revenue was USD 1.37 billion, compared with the USD 1.31 billion analyst estimate, while adjusted earnings per share reached USD 0.34 versus USD 0.27 expected. MarketBeat reported that quarterly revenue increased 10.20 percent year over year and that Elanco set third-quarter adjusted earnings per share guidance at USD 0.19-0.22.

The comparison matters because the next catalyst is measured against a stronger earnings base. MarketBeat also reported that eight of 12 analysts rated Elanco a buy, one rated it a strong buy and the average 12-month price target was USD 29.70. The target is a consensus measure, not a forecast from this article.

Stock remains below yearly high

Elanco's primary listing is the NYSE, where the stock's 52-week range was USD 19.40 to USD 27.98 in the quoted market snapshot. The Lang & Schwarz euro price is a separate German-market reference, so the two currencies are not used to calculate one combined performance figure.

Elanco stock trades above prior close

Elanco stock was trading at EUR 20.23 at Lang & Schwarz on October 6, 2026 at 1:18 p.m. CEST, plus 1.05 percent versus the prior close of EUR 20.02 on October 5, 2026.